These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 28411259)

  • 1. Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Implantation: Systematic Review and Meta-Analysis.
    Bagur R; Solo K; Alghofaili S; Nombela-Franco L; Kwok CS; Hayman S; Siemieniuk RA; Foroutan F; Spencer FA; Vandvik PO; Schäufele TG; Mamas MA
    Stroke; 2017 May; 48(5):1306-1315. PubMed ID: 28411259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral Protection During Transcatheter Aortic Valve Implantation: An Updated Systematic Review and Meta-Analysis.
    Testa L; Latib A; Casenghi M; Gorla R; Colombo A; Bedogni F
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for Cerebral Embolic Prevention in Transcatheter Aortic Valve Implantation and Thoracic Endovascular Aortic Repair.
    Lam HT; Kwong JM; Lam PL; Yeung WL; Chan YC
    Ann Vasc Surg; 2019 Feb; 55():292-306. PubMed ID: 30218830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis.
    Pagnesi M; Martino EA; Chiarito M; Mangieri A; Jabbour RJ; Van Mieghem NM; Kodali SK; Godino C; Landoni G; Colombo A; Latib A
    Int J Cardiol; 2016 Oct; 221():97-106. PubMed ID: 27400304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral embolic protection devices during transcatheter aortic valve implantation, the current state of the art.
    Deveci OS; Okutucu S; Fatihoglu SG; Oto A
    Acta Cardiol; 2022 May; 77(3):196-203. PubMed ID: 33827380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological outcomes of transcatheter aortic valve implantation with or without cerebral embolic protection devices: A meta-analysis.
    Pérez-Camargo D; Travieso A; Carnero-Alcázar M; Taramasso M; Cobiella-Carnicer J; Maroto-Castellanos LC
    J Stroke Cerebrovasc Dis; 2022 Sep; 31(9):106605. PubMed ID: 35843052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological Outcomes With Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Giustino G; Mehran R; Veltkamp R; Faggioni M; Baber U; Dangas GD
    JACC Cardiovasc Interv; 2016 Oct; 9(20):2124-2133. PubMed ID: 27765306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral protection devices for transcatheter aortic valve replacement.
    Jobanputra Y; Jones BM; Mohananey D; Fatima B; Kandregula K; Kapadia SR
    Expert Rev Med Devices; 2017 Jul; 14(7):529-543. PubMed ID: 28658982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral embolic protection systems for transcatheter aortic valve replacement.
    Gasior T; Mangner N; Bijoch J; Wojakowski W
    J Interv Cardiol; 2018 Dec; 31(6):891-898. PubMed ID: 30467892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-Analysis of Usefulness of Cerebral Embolic Protection During Transcatheter Aortic Valve Implantation.
    Ahmad Y; Howard JP
    Am J Cardiol; 2021 May; 146():69-73. PubMed ID: 33556360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis: The CLEAN-TAVI Randomized Clinical Trial.
    Haussig S; Mangner N; Dwyer MG; Lehmkuhl L; Lücke C; Woitek F; Holzhey DM; Mohr FW; Gutberlet M; Zivadinov R; Schuler G; Linke A
    JAMA; 2016 Aug; 316(6):592-601. PubMed ID: 27532914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.
    Seeger J; Gonska B; Otto M; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2297-2303. PubMed ID: 28917515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of cerebral embolic protection devices in patients undergoing transcatheter aortic valve replacement: a meta-analysis of in-hospital outcomes.
    Shimamura J; Kuno T; Malik A; Yokoyama Y; Gupta R; Ahmad H; Briasoulis A
    Cardiovasc Interv Ther; 2022 Jul; 37(3):549-557. PubMed ID: 34773568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral protection devices during transcatheter aortic valve implantation.
    Vlastra W; Vendrik J; Koch KT; Baan J; Piek JJ; Delewi R
    Trends Cardiovasc Med; 2018 Aug; 28(6):412-418. PubMed ID: 29428159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TriGuard
    Samim M; van der Worp B; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Ramjankhan F; Doevendans PA; Stella PR
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):470-477. PubMed ID: 27121306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.
    Latib A; Mangieri A; Vezzulli P; Spagnolo P; Sardanelli F; Fellegara G; Pagnesi M; Giannini F; Falini A; Gorla R; Montorfano M; Bedogni F; Colombo A; Popma J; Merhi WM; De Marco F
    JACC Cardiovasc Interv; 2020 Apr; 13(7):860-868. PubMed ID: 32273098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study.
    Rodés-Cabau J; Kahlert P; Neumann FJ; Schymik G; Webb JG; Amarenco P; Brott T; Garami Z; Gerosa G; Lefèvre T; Plicht B; Pocock SJ; Schlamann M; Thomas M; Diamond B; Merioua I; Beyersdorf F; Vahanian A
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1146-55. PubMed ID: 25341709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation.
    Naber CK; Ghanem A; Abizaid AA; Wolf A; Sinning JM; Werner N; Nickenig G; Schmitz T; Grube E
    EuroIntervention; 2012 May; 8(1):43-50. PubMed ID: 22403768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Cerebral Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: An Updated Meta-Analysis.
    Kaur A; Dhaliwal AS; Sohal S; Gwon Y; Gupta S; Bhatia K; Dominguez AC; Basman C; Tamis-Holland J
    J Am Heart Assoc; 2024 Feb; 13(3):e030587. PubMed ID: 38240252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions.
    Onsea K; Agostoni P; Samim M; Voskuil M; Kluin J; Budde R; Hendrikse J; Ramjankhan F; van Klarenbosch J; Doesburg P; Sieswerda G; Stella P
    EuroIntervention; 2012 May; 8(1):51-6. PubMed ID: 22580248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.